We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rectal Suppository Applicator Improves Therapeutic Efficiency

By HospiMedica International staff writers
Posted on 13 May 2014
A novel applicator offers a dramatic improvement in the quality of life to the millions of people who require suppository medication therapy. More...


The Sephure disposable suppository applicator is an anatomically designed device intended for patients prescribed rectal suppository medication. Using the applicator, patients can quickly, hygienically, and comfortably administer rectal suppositories. The inner structure of the applicator has vents to allow air to exit the body during administration and withdrawal of the applicator into the rectum. The applicator also positions suppositories further into the rectum, away from the nerves that signal the body to expel the contents of the bowel. The device comes in two sizes to fit the most common suppository shapes.

Suppository medication is designed to melt at body temperature; as a result, when the medication has melted and the trapped air is expelled from the body, the medication leaks. By allowing the air to escape, the Sephure applicator eliminates suction effect, leaving the suppository properly placed away from the nerve endings that signal the body to expel the contents of the bowel. As a result, the person does not feel the medication while it melts and is absorbed by the body, and the feeling of urgency to expel the medication is eliminated. When used for administering a laxative suppository, better contact with the lining of the rectum results in a better end result.

The Sephure disposable suppository applicator was designed by Jennifer Davagian Ensign, who was diagnosed with Inflammatory Bowel Disease (IBD) more than 20 years ago and lived with infrequent flares. Depositing a suppository dose took her 30–45 minutes lying in the prone position, inserting the suppository with her finger, and resisting the urgency to release the medication. Upon standing, she needed to wear protective undergarments since the medicine leaked outside the body. Within a few months the regimen became too burdensome and she abandoned her treatment; a serious health scare then led her to create the device.

“At first it was difficult talking about something so private in a public forum,” said Ensign, who is also the CEO of Cristcot (Concord, MA, USA), the company she founded to manufacture the Sephure applicator. “By telling my story I hope to create a new standard of care and in the process, improve the quality of life of others who struggle with the difficulties of suppository treatment.”

Related Links:

Cristcot



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Resorbable Bovine Collagen Membrane
GenDerm
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Surgical Techniques

view channel
Image: The new system uses an AI model that automatically matches one patient’s X-rays with 3D scans in a matter of seconds, and with sub-millimeter precision (Photo courtesy of Vivek Gopalakrishnan, Polina Golland)

Patient-Specific AI Tool Aligns X-Rays With 3D Scans For Surgical Navigation

Minimally invasive procedures rely on real-time X-rays for navigation, but two-dimensional images can obscure the precise location and orientation of instruments inside the body. This uncertainty can prolong... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.